HK1028949A1 - Method and product using sturgeon notochord for alleviating the symptoms of arthritis - Google Patents

Method and product using sturgeon notochord for alleviating the symptoms of arthritis

Info

Publication number
HK1028949A1
HK1028949A1 HK00106105A HK00106105A HK1028949A1 HK 1028949 A1 HK1028949 A1 HK 1028949A1 HK 00106105 A HK00106105 A HK 00106105A HK 00106105 A HK00106105 A HK 00106105A HK 1028949 A1 HK1028949 A1 HK 1028949A1
Authority
HK
Hong Kong
Prior art keywords
notochord
arthritis
alleviating
symptoms
product
Prior art date
Application number
HK00106105A
Other languages
English (en)
Inventor
Seiji Aoyagi
Stephen J Demichele
Paul W Johns
Terrence B Mazer
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of HK1028949A1 publication Critical patent/HK1028949A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Fats And Perfumes (AREA)
  • Saccharide Compounds (AREA)
HK00106105A 1997-07-02 2000-09-26 Method and product using sturgeon notochord for alleviating the symptoms of arthritis HK1028949A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/887,432 US5849336A (en) 1997-07-02 1997-07-02 Method using sturgeon notochord for alleviating the symptoms of arthritis
PCT/US1998/012997 WO1999001147A1 (en) 1997-07-02 1998-06-23 Method and product using sturgeon notochord for alleviating the symptoms of arthritis

Publications (1)

Publication Number Publication Date
HK1028949A1 true HK1028949A1 (en) 2001-03-16

Family

ID=25391113

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00106105A HK1028949A1 (en) 1997-07-02 2000-09-26 Method and product using sturgeon notochord for alleviating the symptoms of arthritis

Country Status (10)

Country Link
US (3) US5849336A (de)
EP (1) EP0988043B1 (de)
AT (1) ATE254924T1 (de)
CA (1) CA2294090C (de)
DE (1) DE69820053T2 (de)
DK (1) DK0988043T3 (de)
ES (1) ES2212310T3 (de)
HK (1) HK1028949A1 (de)
PT (1) PT988043E (de)
WO (1) WO1999001147A1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020025921A1 (en) * 1999-07-26 2002-02-28 Petito George D. Composition and method for growing, protecting, and healing tissues and cells
DE19855890A1 (de) * 1998-12-03 2000-06-08 Nerlich Michael Poröse Kompositmatrix, deren Herstellung und Verwendung
US6524609B1 (en) 1999-08-18 2003-02-25 Nutri-Vet, Llc Treating arthritis in animals with dietary supplements
US6579544B1 (en) 2000-05-31 2003-06-17 Nutriex, L.L.C. Method for supplementing the diet
US6358526B1 (en) 2000-08-16 2002-03-19 Rexall Sundown Method of making tablets and tablet compositions produced therefrom
US6767899B1 (en) * 2000-08-29 2004-07-27 Leiner Health Services Corp. Composition and method for treatment of conditions having an inflammatory component
US20050154046A1 (en) * 2004-01-12 2005-07-14 Longgui Wang Methods of treating an inflammatory-related disease
US7582670B2 (en) * 2001-12-13 2009-09-01 Natrogen Therapeutics, Inc. Methods of treating an inflammatory-related disease
US8563525B2 (en) 2004-01-12 2013-10-22 Natrogen Therapeutics International, Inc. Methods of treating an inflammatory-related disease
US6936686B2 (en) * 2002-12-11 2005-08-30 Nutech Corporation Cross-linked silicone gels; products containing the same; and methods of manufacture thereof
DE602005011768D1 (de) * 2005-05-19 2009-01-29 Samsung Corning Co Ltd Tastatur und Tastaturanordnung
CN101426268B (zh) * 2007-11-02 2010-08-25 大唐移动通信设备有限公司 导频资源分配方法、系统和设备
JP5043215B1 (ja) * 2011-07-01 2012-10-10 国立大学法人北海道大学 チョウザメ類脊索から簡便な抽出方法で得られるｉｉ型コラーゲン
US10833408B2 (en) 2017-07-07 2020-11-10 Rockwell Collins, Inc. Electronically scanned array
ES2905713A1 (es) * 2020-10-09 2022-04-11 Univ Granada Nuevo biomaterial para ingenieria tisular
CN114766553A (zh) * 2022-05-05 2022-07-22 中国海洋大学 鲟鱼龙筋咀嚼片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4473551A (en) * 1982-08-23 1984-09-25 Faxon Pharmaceuticals, Inc. Anti-inflammatory composition
US4925924A (en) * 1984-03-27 1990-05-15 University Of Medicine And Dentistry Of New Jersey Biocompatible synthetic and collagen compositions having a dual-type porosity for treatment of wounds and pressure ulcers and therapeutic methods thereof
CA1302880C (en) * 1986-07-25 1992-06-09 Peter Koepff Agents for the treatment of arthroses
US5399347A (en) * 1987-06-24 1995-03-21 Autoimmune, Inc. Method of treating rheumatoid arthritis with type II collagen
US5075112A (en) * 1990-02-12 1991-12-24 Cartilage Technologies Inc. Method of and dosage unit for inhibiting angiogenesis or vascularization in an animal using shark cartilage
US5529786A (en) * 1994-02-28 1996-06-25 Moore; Eugene R. Process and product for treatment of rheumatoid arthritis
JPH07250887A (ja) * 1994-03-15 1995-10-03 Seikagaku Kogyo Co Ltd 人工血管およびその製造方法
US5709887A (en) * 1995-06-06 1998-01-20 Bryan, Deceased; Clifford R. Method and composition for treating tumors
DE69739275D1 (de) * 1996-01-05 2009-04-09 Autoimmune Inc Methode zur herstellung von type-ii kollagen

Also Published As

Publication number Publication date
US6149946A (en) 2000-11-21
US5849336A (en) 1998-12-15
WO1999001147A1 (en) 1999-01-14
CA2294090C (en) 2003-09-16
EP0988043B1 (de) 2003-11-26
EP0988043A1 (de) 2000-03-29
DE69820053D1 (de) 2004-01-08
DE69820053T2 (de) 2004-08-19
ATE254924T1 (de) 2003-12-15
DK0988043T3 (da) 2004-04-05
US6423347B1 (en) 2002-07-23
ES2212310T3 (es) 2004-07-16
CA2294090A1 (en) 1999-01-14
PT988043E (pt) 2004-04-30

Similar Documents

Publication Publication Date Title
HK1028949A1 (en) Method and product using sturgeon notochord for alleviating the symptoms of arthritis
GEP20032954B (en) Heterocyclic Inhibitors of P38
BG104599A (en) Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas
BG103793A (en) COMBINED THERAPY USING BENZOTHIAPINS INHIBITING THE ILEAL BILE ACID TRANSPORT AND HMG Co-A REDUCTASE INHIBITORS
HK1025737A1 (en) Treatment of multiple sclerosis through ingestion of copolymer-1
BG101118A (en) Therapeutical compounds
HUT77927A (hu) Nebivolol-származékok alkalmazása antiatherogén hatású gyógyászati készítmények előállítására és e vegyületeket tartalmazó kombinációs gyógyászati készítmények
PL309594A1 (en) Apllication of rilusole in treating parkinson disease and parkinsonian syndromes
MX9704030A (es) 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos.
WO1994008551A3 (en) Pharmaceutical compositions and methods for treating cold symptoms
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ZA967880B (en) Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
MXPA94009086A (es) Guanidinas sustituidas terapeuticas.
MX9702926A (es) L-eritrosilnucleosidos.
HUP9900147A2 (hu) Terápiás szerek és autoimmun betegségek kezelésére alkalmas gyógyszerkészítmények
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
MX9707642A (es) Uso de 2-oxoindol-1-carboxamidas 3-sustituidas y sus sales de base farmaceuticamente aceptables para preparar composiciones para el tratamiento y prevencion de la enfermedad de alzheimer en mamiferos, incluyendo a humanos.
EP0744176A3 (de) Arzneimittel zur Hemmung von Knochenschwund
NO20021625L (no) Synergistiske kombinasjoner av en NK1 reseptor antagonist og en GABA strukturell analog
MD970244A (en) Dimer lysozime new application
ATE299699T1 (de) Arzneimittel enthaltend oxaprozin natriumsalz, kaliumsalz, oder tris(hydroxymethyl)aminomethansalz
ITRM960827A0 (it) Medicamento per il trattamento terapeutico della maculopatia legata all'eta', della maculopatia non legata all'eta' e per la profilassi
EP0743068A3 (de) Zusammensetzung zur Hemmung von Knochenverlust welche Vanadylsulfat enthält
EP0564216A3 (en) Pharmaceutical compositions for the treatment and/or prevention of degenerative disorders in the retina

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20080623